Dr. Sudha Sinha Medical Oncologist in Hyderabad

Dr. Sudha Sinha
Medical Oncologist, Hyderabad

MBBS, MD

  • Dr. Sudha Sinha is consultant at MNJ Cancer Hospital and Continental Hospital, Hyderabad

Experience

Consultant, MNJ Cancer Hospital, Hyderabad

Consultant, Continental Hospitals, Hyderabad

Specialities

  • Medical Oncology

  • Surgical Oncology (Cancer Surgery)

  • Oncology

Expertise

Education

MBBS, 1996, Gandhi Medical College, University of Health Sciences, Hyderabad

Practice Information

American Oncology Institute, Hyderabad

American Oncology Institute, Hyderabad

Nallagandla, Serilingampally, Hyderabad, Telangana - 500019

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr. Sudha Sinha and her staff know how they are doing and how they can improve their services.

Achievements & Contributions

  • Digumarti R, Sinha S, Nirni SS, Patil SG, Pedapenki RM. Indian J Cancer. 2014 Apr-Jun;51(2):180-3. Efficacy of rasburicase (recombinant urate oxidase) in the prevention and treatment of malignancy-associated hyperuricemia: an Indian experience.
  • Cingeetham A, Vuree S, Dunna NR, Gorre M, Nanchari SR, Edathara PM, Meka P, Annamaneni S, Digumarthi R, Sinha S, Satti V. Tumour Biol. 2015 May 10. [Epub ahead of print]. Influence of BCL2-938C >A and BAX-248G>A promoter polymorphisms in the development of AML: case-control study from South India
  • Cingeetham A1, Vuree S, Jiwatani S, Kagita S, Dunna NR, Meka PB, Gorre M, Annamaneni S, Digumarti R, Sinha S, Satti V. Asian Pac J Cancer Prev. 2015;16(7):2707-12. Role of the MDM2 promoter polymorphism (-309T>G) in acute myeloid leukemia development
  • Cingeetham A, Vuree S, Dunna NR, Gorre M, Nanchari SR, Edathara PM, Mekkaw P, Annamaneni S, Digumarthi RR, Sinha S, Satti V.Tumour Biol. 2014 Sep;35(9):8813-22. Association of caspase9 promoter polymorphisms with the susceptibility of AML in south Indian subjects.
  • Chiranjeevi P, Spurthi KM, Rani NS, Kumar GR, Aiyengar TM, Saraswati M, Srilatha G, Kumar GK, Sinha S, Kumari CS, Reddy BN, Vishnupriya S, Rani HS. Tumour Biol. 2013 Dec 20. [Epub ahead of print]. Gelatinase B (-1562C/T) polymorphism in tumor progression and invasion of breast cancer.
  • Anuradha V, Anand BB, Suresh AV, Sinha S, Babu SC, Suresh K.Indian J Med Paediatr Oncol. 2013 Jan;34(1):11-5. Palliative chemotherapy in head and neck squamous cell cancer – What is best in Indian population? A time without symptoms, treatment toxicity score based study.